Avantra Biosciences Corp
Funding rounds
5 counted as startup funding. Open the number of investors for the round's details.
| Month | Raised | Raise | Size | Investors | Sold | Filing |
|---|---|---|---|---|---|---|
| Dec 2020 | $3 M | No. 5 | $2 to $10 million | equity | SEC | |
| Sep 2017 | $5 M | No. 4 | $2 to $10 million | debt, options | SEC | |
| Jun 2015 | $8 M | No. 3 | $2 to $10 million | equity | SEC | |
| Oct 2011 | $8 M | No. 2 | $2 to $10 million | equity | SEC | |
| Jul 2010 | $7 M | No. 1 | $2 to $10 million | equity | SEC |
How it makes money#
What its filings and its own website say, sentence by sentence, each with its source.
Avantra Biosciences Corp chose not to state its revenue in its newest notice of a funding round (Apr 2021).
SEC Form D · Apr 2021
The industry group it chose in its notices: Biotechnology.
SEC Form D · Apr 2021
Products and services#
No products or services on record: no website is on record for it in an official source (its SEC filings, Wikidata).
Investors#
No investor of Avantra Biosciences Corp is named in an official source we use. Its funding notices give only how many investors bought, not who they are.
Executives and directors
As the company named them in its notices. Directors of a funded startup are often partners of its investors.
| Name | Role | Named in |
|---|---|---|
| Brendan L McKernan | Executive officer | Apr 2021 |
| Kevin J. McKernan | Executive officer | Apr 2021 |
| Patrick J. Costello | Executive officer | Apr 2021 |
| Brendan L. McKernan | Executive officer | Nov 2017 |
| Patrick B. Costello | Secretary | Jun 2015 |
| R. Brian McKernan | Chief Executive Officer | Jun 2015 |
| John J. Altorelli | Secretary | Oct 2011 |
| Brendan L McKernan | Director | Apr 2021 |
| Charles M Farkas | Director | Apr 2021 |
| Mark H DeBlois | Director | Apr 2021 |
| Philip J. Chapman | Director | Apr 2021 |
| Richard M McKernan | Director | Apr 2021 |
| Richard M Upton | Director | Apr 2021 |
| Brendan L. McKernan | Director | Nov 2017 |
| Charles M. Farkas | Director | Nov 2017 |
| Mark H. DeBlois | Director | Nov 2017 |
| Richard T. McKernan | Director | Nov 2017 |
| Richard T. Upton | Director | Nov 2017 |
| Emery G. Olcott | Director | Jun 2015 |
| John J. Altorelli | Director | Jun 2015 |
| R. Brian McKernan | Chief Executive Officer | Jun 2015 |
| Richard J. Upton | Director | Jun 2015 |
| Stephen M. McLean | Director | Jun 2015 |
| Philip M. Chapman | Director | Aug 2010 |
| Richard M. Upton | Director | Aug 2010 |